James Oleske

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source:Rutgers

James M. Oleske, MPH, MD, is a professor of Pediatrics at Rutgers New Jersey Medical School and the Director of Division of Pediatric Allergy, Immunology and Infectious diseases and director of the Pediatric palliative care program.[1]

From 2006 to 2009, he served as the Committee Chair of the Chronic Fatigue Syndrome Advisory Committee.[2]

Education[edit]

As per Rutgers New Jersey Medical School bio page[3]

  • 1967, BS, University of Detroit
  • 1971, MD, College of Medicine & Dentistry of NJ
  • 1974, MPH, Columbia University
  • 1974, Pediatric residency and a fellowship in Ambulatory Pediatrics at Harrison S Martland Hospital in *1976, National Cancer Institute fellowship in Pediatric Allergy, Immunology and Infectious disease at Emory University and CDC, Atlanta, Georgia

Awards[edit]

  • 2013, Life-time Achievement Award for Pediatric HIV/AIDS Work from the American Academy of Pediatrics Committee on Pediatric AIDS[4]
  • 2002, NJ-Chronic Fatigue Syndrome Association (now the New Jersey ME/CFS Association Award of Service.[5]

Books[edit]

Open Letter to The Lancet[edit]

Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Oleske, along with 41 colleagues in the ME/CFS field, signed the second letter.

Notable studies[edit]

  • 2006, Chronic Fatigue Syndrome in Children and Adolescents
    "Abstract - Objective: An overview of the unique aspects of Chronic Fatigue Syndrome in children and adolescents (CACFS) is herein provided for healthcare professionals who may be called upon to diagnose and/or treat this illness. Young age of onset, puberty, and interactions with peers and the educational system provide greater diagnostic and treatment challenges than found with adult onset CFS. Method: A review of diagnostic procedures and treatment protocols found in the contemporary literature is coupled with the professional experiences of the authors in treating CACFS to delineate the roles and responsibilities of family, healthcare providers and educators in diagnosing, treating and supporting the CACFS patient. Results: Areas discussed include: pathogenesis, patient evaluation, clinical evaluation, laboratory evaluation, treatment options, psychological issues, role of schools, and the roles of primary and tertiary care providers. Conclusion: CACFS can be diagnosed and treated with varying levels of success if all the professionals involved in the treatment program have a clear understanding of their roles and responsibilities. Primary care physicians, pediatricians, other subspecialists, family members, social workers and educators, may all be called upon to participate in the treatment program of CACFS. While it is best to have one, compassionate physician in charge of care, the CACFS may benefit from the inclusion of specialized treatment options available from or through a tertiary care provider. To the extent possible, socialization, education and psychological support of the CACFS should be provided."[8]
  • 2004, Immunologic Aspects of Chronic Fatigue Syndrome: Report on a Research Symposium Convened by The CFIDS Association of America and Co-Sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health
    "Abstract - Chronic fatigue syndrome (CFS) is a serious health concern affecting over 800,000 Americans of all ages, races, socioeconomic groups and genders. The etiology and pathophysiology of CFS are unknown, yet studies have suggested an involvement of the immune system. A symposium was organized in October 2001 to explore the possibility of an association between immune dysfunction and CFS, with special emphasis on the interactions between immune dysfunction and other abnormalities noted in the neuroendocrine and autonomic nervous systems of individuals with CFS. This paper represents the consensus of the panel of experts who participated in this meeting. Data suggest that persons with CFS manifest changes in immune responses that fall outside normative ranges, but current research does not provide definitive evidence on whether these immune abnormalities are a cause or result of the illness. It has become clear that CFS cannot be understood based on single measurements of immune, endocrine, cardiovascular, or autonomic nervous system dysfunction. This panel encourages a new emphasis on multidisciplinary research into CFS."[9]

Talks & interviews[edit]

Online presence[edit]

Learn more[edit]

See also[edit]

Chronic Fatigue Syndrome Advisory Committee

References[edit]

  1. http://njms.rutgers.edu/resource_locator/find_people/profile.cfm?mbmid=oleskejm#tab-bio
  2. http://njms.rutgers.edu/unmanaged/CV/oleskejm.pdf
  3. http://njms.rutgers.edu/resource_locator/find_people/profile.cfm?mbmid=oleskejm#tab-bio
  4. http://ireport.cnn.com/docs/DOC-944602
  5. http://njms.rutgers.edu/unmanaged/CV/oleskejm.pdf
  6. A Consensus Manual for the Primary Care and Management of Chronic Fatigue Syndrome - 2002 by The Academy of Medicine of New Jersey and the New Jersey Department of Health and Senior Services
  7. Fisher, Gregg Charles; Cheney, Paul; Straus, Stephen; Gantz, Nelson M.; Klonoff, David C.; Oleske, James M. (1997), Chronic Fatigue Syndrome: A Comprehensive Guide to Symptoms, Treatments, and Solving the Practical Problems of CFS (book), Grand Central Publishing 
  8. Oleske, James M.; Friedman, Kenneth J.; Kaufman, Kenneth R.; Palumbo, Donna; Sterling, Jonathan; Evans, Terri Lynn (2006), "Chronic Fatigue Syndrome in Children and Adolescents", Journal of Chronic Fatigue Syndrome, 13 (2-3), doi:10.1300/J092v13n02_07 
  9. Gerrity, T.R.; Papanicolaou, D.A.; Amsterdam, J.D.; Bingham, S.; Grossman, A.; Hedrick, T.; Herberman, R.B.; Krueger, G.; Levine, S.; Mohagheghpour, N.; Moore, R.C.; Oleske, J.M.; Snell, C.R.; CFIDS Association of America (2004), "Immunologic Aspects of Chronic Fatigue Syndrome: Report on a Research Symposium Convened by The CFIDS Association of America and Co-Sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health", Neuroimmunomodulation, 11: 351–357, PMID 15467349, doi:10.1159/000080144 


The information provided at this site is not intended to diagnose or treat any illness.

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history